Page 26 - MemoriaDEM-Eng

HORIZONTAL PROGRAMMES AND PLATFORMS

Platforms

CIBERDEM BIOBANK

http://www.ciberdem.org/biobanco.php

ííí

The objective of the CIBERDEM Biobank is to make well characterized and standardized
biological samples of main metabolic disorders with a high added value available to the

scientific community to promote, facilitate and develop biomedical research according

to the laws in force.

The CIBERDEM Biobank consists of CIBERDEM groups in the following centres:

íá
• Hospital Clnic de Barcelona: Dr. Ramon Gomis and Dr. Anna Novials

• Hospital Joan XXIII: Dr. Joan Vendrell

• Hospital Sant Joan de Reus: Dr. Masana
ñ
• Hospital de Cruces: Dr. Lus Castao

• Hospital Clnico de Madrid: Dr. Serrano-Ríos

• Hospital Clnico de Valencia: Dr. Carmena

• Hospital Carlos Haya de Mlaga: Dr. C. Soriguer

•
Hospital de la Santa Creu i Sant Pau: Dr. Blanco-Vaca

Donor information is stored in the BCGene computer platform. This application com-
plies with the requirements of Organic Law on Personal Data Protection 15/1999 and

will be accessible from all participating nodes to facilitate data entry by clinical teams.
13
In 2013, the sample collection was enlarged with the inclusion of diabetic patients 20
T
with monogenic diabetes. Furthermore, a DNA bank of the ancient population of the R
Roman city of Tarraco was established in 2013 in the framework of the MEDIGENE PO
E
project. This DNA Bank will be one-of-a-kind worldwide and will provide a basis for L R
studying the origin and progression of many diseases. Likewise, individuals at risk for A
NU
developing diabetes started to be included in the Predaps study (GDPS Network) in N
A
order to determine the risk of diabetes and the risk of vascular complications /
in prediabetic patients and to identify the factors associated with those risks.
EM
D
ER
B
CI

26